| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/28/2006 | WO2006014576A3 Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals |
| 09/28/2006 | WO2006000576B1 Methods and compositions to promote bone homeostasis |
| 09/28/2006 | WO2005117880A3 Methods for treating anxiety disorders and related article of manufacture |
| 09/28/2006 | WO2005116633A3 Magnetic particle resuspension probe module |
| 09/28/2006 | WO2005114139A3 Polymer melt and elastomer extension fixture |
| 09/28/2006 | WO2005096779A3 Clot retainer |
| 09/28/2006 | WO2005094422A3 Angiocidin fragments and uses thereof in clinical assays for cancer and other diseases |
| 09/28/2006 | WO2005074650A3 Modified human four helical bundle polypeptides and their uses |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2005054493A3 Altered activity of toll-like receptors |
| 09/28/2006 | WO2005052134A3 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 09/28/2006 | WO2005034732A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/28/2006 | WO2005028489A3 Novel adenosine a3 receptor agonists |
| 09/28/2006 | WO2004076682A3 Targets for controlling cellular growth and for diagnostic methods |
| 09/28/2006 | WO2004075830A3 Knockout identification of target-specific sites in peptides |
| 09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/28/2006 | WO2004069174A3 Monitoring and treatment of amyotrophic lateral sclerosis |
| 09/28/2006 | WO2004024090A3 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 09/28/2006 | WO2002083872A3 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060218010 Systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations |
| 09/28/2006 | US20060217913 System, Method, and Computer Software Product for Gain Adjustment in Biological Microarray Scanner |
| 09/28/2006 | US20060217634 Device for collecting skin permeable gas and apparatus for measuring skin permeable gas |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217319 Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 09/28/2006 | US20060217305 Induction of tumor cell senescence by retinoid receptor agonists and antagonists |
| 09/28/2006 | US20060216835 Method of separating unattached Raman-active tag from bioassay or other reaction mixture |
| 09/28/2006 | US20060216834 containing detectable probe and labels which generate signal when detecting analyte within test sample; spherical shape, formed by electrostatic layer deposition; use in flow-through and diffraction-based systems |
| 09/28/2006 | US20060216833 Spot test kit for explosives detection |
| 09/28/2006 | US20060216832 Reader for immunochromatographic test, cartridge applicable to this, and system for examining immunochromatographic test piece |
| 09/28/2006 | US20060216829 Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same |
| 09/28/2006 | US20060216828 Rapid-response reversible dry surface CO2 detector |
| 09/28/2006 | US20060216825 Method for characterizing biological indicators n sterilization processes and apparatus for the implementation thereof |
| 09/28/2006 | US20060216817 Test device for analyzing body fluids |
| 09/28/2006 | US20060216814 Molecule detecting method, molecule counting method, molecule localization detecting method, and molecule detecting device used for them |
| 09/28/2006 | US20060216813 Dna chip comprising a microarray made of an microelectrode system |
| 09/28/2006 | US20060216791 Method for synthesizing amino-acid-selectively labeled protein |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216781 Apparatus capable of creating paraffin-embedded biological arrays as well as frozen biological arrays; less complex and more efficient; enables receptacle in recipient block be filled prior to forming an adjacent receptacle and deformation of the donor core is minimized during deposition into receptacle |
| 09/28/2006 | US20060216779 Method for the detection of post-translational modification activities and device system for carrying out said method |
| 09/28/2006 | US20060216778 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 09/28/2006 | US20060216777 Immobilization on solid support |
| 09/28/2006 | US20060216776 Screening assay for agents that alter target of rapamycin activity |
| 09/28/2006 | US20060216772 Interfacial biomaterials for binding metal substrates |
| 09/28/2006 | US20060216771 Method for detecting carcinomas in a solubilized cervical body sample |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | US20060216769 Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects |
| 09/28/2006 | US20060216768 Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays |
| 09/28/2006 | US20060216767 Docetaxel immunoassay |
| 09/28/2006 | US20060216766 Assay for protein isoforms |
| 09/28/2006 | US20060216765 Apparatus, methods and systems for rapid microbial testing |
| 09/28/2006 | US20060216764 Diagnosing prostate cancer in humans; obtaining tissue sample, monitoring marker gene expression, evaluating pattern for cancer; diagnostic and prognostic assays include methods involving the antibody-based detection of Pin1 and the amplification of Pin1 RNA |
| 09/28/2006 | US20060216763 Methods for predicting and/or diagnosing the risk of gastric cancer |
| 09/28/2006 | US20060216762 Extracting reagent for hydrophobic analyte in whole blood |
| 09/28/2006 | US20060216761 Isolation material for hormone disrupting substance, method of concentrating and method of clean-up |
| 09/28/2006 | US20060216760 Methods for proteomic profiling using non-natural amino acids |
| 09/28/2006 | US20060216759 Functionalized fluorescent nanocrystals, and methods for their preparation and use |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216757 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 09/28/2006 | US20060216756 Method for evaluating oxidized protein in horny cell layer |
| 09/28/2006 | US20060216755 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 09/28/2006 | US20060216753 Modified and glucose/galactose binding protein comprising thiol groups for use in monitoring blood glucose/galactose concentrations of diabetics |
| 09/28/2006 | US20060216752 Binding Protein as Biosensors |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216749 Chimeric gaba receptor |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216743 use low-energy spectroscopy to detect biomolecular binding events between molecules in an aqueous solution; Raman spectroscopy |
| 09/28/2006 | US20060216742 Methods and systems for detecting biomolecular binding using terahertz radiation |
| 09/28/2006 | US20060216740 Methods for the electronic, homogeneous assembly and fabrication of devices |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216730 Novel human protein kinases and protein kinase-like enzymes |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216726 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry |
| 09/28/2006 | US20060216719 Novel short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
| 09/28/2006 | US20060216716 Immunologic activity measures for t helper on-associated conditions |
| 09/28/2006 | US20060216714 detecting a tumor biomarker (COX-2) for diagnosing colon cancer; comprises freezing sample immediately after collection, homogenizing sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA which us then amplified for detection |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216706 Proteins associated with cell growth, differentiation, and death |
| 09/28/2006 | US20060216705 Transcription activation complex and utilization thereof |
| 09/28/2006 | US20060216704 Water-soluble conjugates for electrochemical detection |
| 09/28/2006 | US20060216703 Extraction and concentration method |
| 09/28/2006 | US20060216701 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216697 Method of separating unattached Raman-active tag from bioassay or other reaction mixture |
| 09/28/2006 | US20060216696 Rapid plague detection system |
| 09/28/2006 | US20060216695 Diluent for norovirus or sapovirus specimen and method for detecting virus |
| 09/28/2006 | US20060216694 Use of a virus expressing a binding moiety to measure analytes in a sample |
| 09/28/2006 | US20060216693 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 09/28/2006 | US20060216691 contacting MHC/HLA molecule with a pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to MHC/HLA molecule binds to such MHC/HLA molecule and form a complex, detecting the complexe, assaying the complex in a T cell assay for T cell activation capacity, assaying T cell epitopes |
| 09/28/2006 | US20060216690 Ion channel assay methods |
| 09/28/2006 | US20060216689 Ion channel assay methods |
| 09/28/2006 | US20060216688 Ion channel assay methods |
| 09/28/2006 | US20060216310 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |